Janney Montgomery Scott LLC cut its holdings in Balchem Corporation (NASDAQ:BCPC – Free Report) by 7.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 2,730 shares of the basic materials company’s stock after selling 226 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Balchem were worth $453,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the business. Vista Finance LLC lifted its position in Balchem by 7.0% in the 1st quarter. Vista Finance LLC now owns 1,347 shares of the basic materials company’s stock valued at $224,000 after acquiring an additional 88 shares in the last quarter. Azzad Asset Management Inc. ADV raised its stake in shares of Balchem by 3.0% in the 1st quarter. Azzad Asset Management Inc. ADV now owns 5,819 shares of the basic materials company’s stock valued at $966,000 after purchasing an additional 171 shares during the period. Assenagon Asset Management S.A. lifted its holdings in shares of Balchem by 343.2% in the first quarter. Assenagon Asset Management S.A. now owns 66,309 shares of the basic materials company’s stock valued at $11,007,000 after purchasing an additional 51,348 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Balchem in the first quarter valued at about $1,148,000. Finally, GAMMA Investing LLC boosted its position in shares of Balchem by 22.5% during the first quarter. GAMMA Investing LLC now owns 1,068 shares of the basic materials company’s stock worth $177,000 after buying an additional 196 shares during the period. 87.91% of the stock is owned by institutional investors.
Balchem Stock Up 1.1%
Shares of BCPC stock opened at $164.92 on Friday. The firm’s fifty day moving average price is $163.17 and its two-hundred day moving average price is $163.13. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. Balchem Corporation has a 1 year low of $145.70 and a 1 year high of $186.03. The firm has a market capitalization of $5.38 billion, a P/E ratio of 39.55, a PEG ratio of 3.52 and a beta of 0.89.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the company. Wall Street Zen lowered Balchem from a “buy” rating to a “hold” rating in a research report on Wednesday, May 21st. HC Wainwright set a $180.00 price target on shares of Balchem and gave the stock a “buy” rating in a research note on Monday, April 28th.
View Our Latest Research Report on Balchem
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Further Reading
- Five stocks we like better than Balchem
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- The Basics of Support and Resistance
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Corporation (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.